SG Americas Securities LLC reduced its stake in Clorox Company (The) (NYSE:CLX) by 15.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,322 shares of the company’s stock after selling 2,699 shares during the period. SG Americas Securities LLC’s holdings in Clorox Company (The) were worth $1,908,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock valued at $1,909,829,000 after buying an additional 649,766 shares during the last quarter. BlackRock Inc. raised its stake in Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock valued at $1,400,912,000 after buying an additional 9,698,542 shares during the last quarter. State Street Corp raised its stake in Clorox Company (The) by 2.2% in the first quarter. State Street Corp now owns 7,648,999 shares of the company’s stock valued at $1,031,304,000 after buying an additional 167,689 shares during the last quarter. Parnassus Investments CA acquired a new stake in Clorox Company (The) during the first quarter valued at about $434,255,000. Finally, Valueinvest Asset Management S.A. raised its stake in Clorox Company (The) by 6.9% in the first quarter. Valueinvest Asset Management S.A. now owns 1,580,400 shares of the company’s stock valued at $213,085,000 after buying an additional 102,300 shares during the last quarter. Institutional investors own 69.83% of the company’s stock.

Shares of Clorox Company (NYSE:CLX) opened at 137.48 on Friday. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76. The stock has a market capitalization of $17.74 billion, a price-to-earnings ratio of 25.77 and a beta of 0.40. The stock’s 50 day moving average is $134.18 and its 200-day moving average is $134.70.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same period last year, the business earned $1.30 earnings per share. Clorox Company (The)’s revenue was up 2.9% compared to the same quarter last year. On average, analysts expect that Clorox Company will post $5.67 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “SG Americas Securities LLC Decreases Stake in Clorox Company (The) (CLX)” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/08/27/sg-americas-securities-llc-decreases-stake-in-clorox-company-the-clx.html.

CLX has been the subject of several analyst reports. BidaskClub lowered shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a research report on Wednesday, July 5th. Zacks Investment Research upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price target for the company in a research report on Tuesday, July 4th. Deutsche Bank AG restated a “hold” rating and set a $137.00 price target (up from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. Jefferies Group LLC set a $138.00 price target on shares of Clorox Company (The) and gave the company a “hold” rating in a research report on Wednesday, May 3rd. Finally, BMO Capital Markets restated a “buy” rating and set a $136.00 price target on shares of Clorox Company (The) in a research report on Thursday, May 4th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. Clorox Company (The) currently has a consensus rating of “Hold” and an average price target of $129.05.

In related news, SVP Jon M. Balousek sold 9,223 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the completion of the sale, the senior vice president now directly owns 20,614 shares in the company, valued at $2,862,666.18. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP James E. Foster sold 9,861 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the sale, the executive vice president now owns 22,069 shares of the company’s stock, valued at $3,056,777.19. The disclosure for this sale can be found here. 0.74% of the stock is currently owned by company insiders.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.